TRIPS waiver for COVID-19​ tools: What are the implications for Africa?

On 2 October 2020, India and South Africa asked the World Trade Organization (WTO) to allow all countries to choose to neither grant nor enforce patents and other intellectual property (IP) rights related to COVID-19 drugs, vaccines, diagnostics, and other technologies for the duration of the pandemic, until global herd immunity is achieved.

Médecins Sans Frontières (MSF) and Drugs for Neglected Diseases initiative (DNDi) hosted this webinar to discuss the implications of the TRIPs waiver proposal for Africa, and why countries should support it.

Watch the recording



  • Spring Gombe, Programme Manager for Technology Access Partnership at UN Technology Bank for the Least Developed Countries
  • Mustaqeem De Gama, Counsellor, the Permanent Mission of South Africa in Geneva
  • Dr Hu Yuan Qiong, Senior Legal & Policy Advisor, Médecins Sans Frontières Access Campaign
  • Dr Ahmed Ogwell Ouma, Deputy Director, Africa CDC
  • Moses Mulumba, Executive Director, CEHURD
  • Dr Monique Wasunna, Director DNDi Africa, Kenya


More information about the webinar

Sign-up for our monthly newsletter.